Brian Malkin joins GW Law for their “FDA-PTO Roundtable.” Brian and panel discuss “several recent letters sent by the Acting Commissioner of Food and Drugs and Members of Congress to the Patent and Trademark Office concerning drug-related patents and pharmaceutical pricing.”

Learn more and register here.